Medicine and Dentistry
Child Health
100%
Human Immunodeficiency Virus
54%
Pneumococcus Vaccine
47%
Disease
43%
Pathogen
40%
Streptococcus Pneumoniae
36%
Toddlers
30%
Pneumococcal Infection
27%
Case-Control Study
27%
Thorax Radiography
25%
Human Respiratory Syncytial Virus
24%
Systematic Review
23%
Induced Sputum
21%
Chest Radiograph
20%
Cohort Effect
20%
Serotype
20%
Low and Middle Income Countries
18%
Health Care Cost
17%
Household
17%
Polymerase Chain Reaction
16%
Prevalence
14%
Meningitis
14%
COVID-19
14%
Pneumococcal Pneumonia
14%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Cost-Effectiveness Analysis
13%
Respiratory Tract Infection
12%
Infection
12%
Pneumococcus
12%
Haemophilus Influenzae Type B
12%
Odds Ratio
11%
Community-Acquired Pneumonia
10%
Haemophilus influenzae
10%
Pediatric Pneumonia
10%
Upper Respiratory Tract
9%
Diagnosis
9%
Disease Burden
9%
Wheeze
9%
Symptom
8%
Childhood Mortality
8%
Pneumocystis Pneumonia
8%
Human Immunodeficiency Virus Infection
8%
Lung Aspiration
8%
Vaccine
7%
Case Fatality Rate
7%
Staphylococcus Aureus
7%
Decision Making
7%
Blood Culture
7%
Meta-Analysis
7%
Case Definition
7%
Keyphrases
Pneumonia Etiology Research for Child Health
68%
Pneumonia
63%
Health Studies
52%
Pneumococcal Conjugate Vaccine
34%
Pneumonia Etiology
28%
COVID-19
27%
Streptococcus Pneumoniae
25%
Young children
23%
World Health Organization
21%
HIV Patients
21%
Etiology
20%
Gambia
20%
Childhood Pneumonia
20%
Respiratory Syncytial Virus
19%
Credible Interval
18%
Very Severe Pneumonia
17%
13-valent Pneumococcal Conjugate Vaccine (PCV13)
16%
Invasive Pneumococcal Disease
16%
Neutralizing Antibodies
16%
Severe Pneumonia
15%
Polymerase Chain Reaction
15%
Immunogenicity
14%
Bangladesh
13%
Chest Radiograph
13%
Dosing Schedule
13%
Induced Sputum
13%
Disease Burden
11%
China
10%
Community Control
10%
Epidemiology
10%
Nasopharyngeal
10%
Immunization
10%
Low-middle Income Countries
10%
PCV10
10%
Revaccination
10%
Acute Lower Respiratory Infection
9%
Population-based Surveillance
9%
Adjusted Odds Ratio
9%
Vaccine Effectiveness
8%
Confidence Interval
8%
Meta-analysis
8%
Haemophilus Influenzae Type b
8%
Nasopharyngeal Swab
8%
Antibody Response
8%
Mycobacterium Tuberculosis (M. tb)
8%
COVID-19 Vaccine
8%
Risk Factors
7%
Wheezing
7%
Thailand
7%
Pneumococcus
7%